Luxembourg vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Luxembourg
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Luxembourg rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Luxembourg
- Sri Lanka
How they compare
Luxembourg currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2011 it was Sri Lanka ahead.
Luxembourg ranks 1st and Sri Lanka ranks 1st of 180 countries.
Luxembourg has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 77.5% | 22.5% | Luxembourg |
| 2020s | 93.8% | 81.5% | 12.2% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Luxembourg or Sri Lanka?
- Luxembourg, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Luxembourg and Sri Lanka?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Sri Lanka?
- 6 years are reported by both, from 2011 to 2024.
- How do Luxembourg and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Luxembourg ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.